tikagrelor

Tikagrelor is an antiplatelet medication used to prevent blood clots in people with certain heart conditions. It is a P2Y12 inhibitor, meaning it blocks a specific receptor on platelets that is involved in their activation and aggregation. By preventing platelets from clumping together, tikagrelor reduces the risk of serious cardiovascular events such as heart attack and stroke.

This medication is typically prescribed to patients who have experienced a recent acute coronary syndrome, such as unstable angina or myocardial infarction, and have undergone procedures like percutaneous coronary intervention. It is often given in combination with aspirin. The dosage and duration of treatment are determined by a healthcare professional based on the individual patient's condition and risk factors.

Like all medications, tikagrelor can have side effects. Common side effects include bleeding, shortness of breath, and bruising. More serious side effects are rare but can include severe bleeding, which may require immediate medical attention. Patients should inform their doctor about any pre-existing medical conditions, especially bleeding disorders, and any other medications they are taking, including over-the-counter drugs and herbal supplements, as these can interact with tikagrelor. Regular monitoring by a healthcare provider is important during treatment with tikagrelor.